Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Novo Nordisk is out with results this morning now lowering its fullear profit uh and revenue uh forecast. Meanwhile, uh the company it's it's getting very interesting in terms uh of uh this possible uh bidding war uh that uh that we are seeing as we move that up a little bit please. That's what this means.Yeah, there you go. Keep going. Keep going. Keep going.Joining us now, Novo Nordis CEO Mike Dudstar. It's good to have you on. Uh can we talk uh about how much this is uh cherished this company met very sm ...